Geneos Wealth Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,260
Closed -$18K 2844
2021
Q1
$18K Sell
3,260
-1,200
-27% -$6.63K ﹤0.01% 2117
2020
Q4
$22K Buy
+4,460
New +$22K ﹤0.01% 1839